Year: 2022

COLUMBIA, Md., Dec. 12, 2022 (GLOBE NEWSWIRE) — Tenable®, the Exposure Management company, today published the results of a global study that revealed that cybersecurity is the top consideration as businesses decide on investing in the metaverse. In fact, even in a challenging global economy, concerns about macroeconomic conditions trailed behind cybersecurity worries. This sentiment underscores the rising criticality of cybersecurity in a digital economy to ensure it is a safe and secure environment for users. The study, “Measure Twice, Cut Once: Meta-curious Organizations Relay Security Concerns Even as They Plunge Into Virtual Worlds,” surveyed 1,500 IT, cybersecurity and DevOps professionals in Australia, the U.K. and U.S. The study examines how organizations are approaching the opportunities and challenges associated with...

This Represents the Tenth Western Defense Agency Served by The Company Waltham, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, announced today that it has received a purchase order from a European army, for a DragonFly IV, the leading Additive Manufacturing Electronics (AME) 3D-printer. This customer is the tenth western defense agency to become a user of Nano Dimension’s high performance additive manufacturing systems. For reasons of national security, Nano Dimension cannot reveal the name of the country it is from, but this is clearly a continuation of the company’s success in providing leading technology...

ATHENS, Greece, Dec. 12, 2022 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has extended the time charter contract with SwissMarine Pte Ltd., Singapore, for one of its Post-Panamax dry bulk vessels, the m/v Alcmene. The gross charter rate is US$13,000 per day, minus a 5% commission paid to third parties, for a period until minimum January 10, 2024 up to maximum March 25, 2024. The new charter period is expected to commence on December 27, 2022. The “Alcmene” is a 93,193 dwt Post-Panamax dry bulk vessel built in 2010. The employment of “Alcmene” is anticipated to generate approximately US$4.86 million of gross revenue for the minimum scheduled...

EXTON, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, today announced that it has priced its concurrent underwritten public offerings of 27,841,737 shares of its common stock at a price to the public of $1.10 per common share and (ii) 450,000 shares of its Series A convertible preferred stock, which will be convertible into 4,500,000 shares of its common stock, at a price to the public of $11.0 per Series A share. The gross proceeds of the offerings are expected to be approximately $35.6 million, prior to deducting the underwriting discounts and estimated offering expenses. The offerings are expected to close...

New York, NY, Dec. 12, 2022 (GLOBE NEWSWIRE) — NuGene International, Inc./Livento Group, Inc. (OTC Pink: NUGN), a dynamic group that specializes in acquiring and developing companies with disruptive business models in film, content, and technology for fund managers, announced today signing a binding Letter of Intent for the acquisition of a Software Engineering Company focused on AI and Robotics. “We are excited to announce that we finalized our due diligence and valuation negotiations,” commented David Stybr Livento Group CEO. “We are at the stage where we have confirmed our intentions in the transaction, and we have drafted the final closing documentation and established the process regarding this acquisition. We assume we will sign the final documentation in January 2023, at which point, full information about the transaction...

VALENCIA, Calif., and MELBOURNE, Australia, Dec. 12, 2022 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today the submission of a Premarket Approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for the company’s RECELL® System. The supplement, if approved, will expand the indication of RECELL to include soft tissue repair. “The submission is a significant milestone in our effort to expand the label of RECELL into the soft tissue repair market opportunity,” said Jim Corbett, AVITA Medical Chief Executive Officer. “Soft tissue repair encompasses a broad label of RECELL applications and allows us to target all level...

LAS VEGAS, NV, Dec. 12, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Elray Resources Inc. (OTCPK: ELRA), a developer and licensor of online gaming technology and systems, today announced it has acquired Online Casino Crypto Technology, from Luxor Capital LLC. The Crypto Technology will enable Elray to build and supply full turnkey Crypto Technology systems to online crypto gaming operators. The crypto platform, branded as EBS (Elray Blockchain System), is expected to launch in the coming months. Elray also announced it has reached an Exclusive Distribution Agreement with Golden Matrix Group Inc. (NASDAQ: GMGI), wherein it will acquire all its gaming content for crypto operators from Golden Matrix. As a result, Elray Gaming’s B2B online crypto casino systems and technology will feature content provided exclusively by Golden Matrix...

The ClearPoint Prism™ Neuro Laser Therapy System The ClearPoint Prism™ Neuro Laser Therapy SystemSOLANA BEACH, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced enrollment of the first patient in a Glioblastoma clinical trial using the ClearPoint Prism™ Neuro Laser Therapy System at Skåne University Hospital in Lund, Sweden (SUS Lund). The Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions study, sponsored by Clinical Laserthermia Systems AB (CLS – Lund, Sweden), is a single-center, single-arm, prospective clinical trial evaluating the safety and feasibility of using the minimally invasive MR-guided laser therapy system to ablate...

GPOX to create multiple medicated products based on the iconic Yuengling’s Ice Cream flavorsGPOPlus+ Assigned Exclusive Trademark License Agreement for the Creation of Yuengling’s Ice Cream Flavored CBD + Cannabinoid Products GPOX to create multiple medicated products based on the iconic Yuengling’s Ice Cream flavorsLas Vegas, NV and Atlanta, GA, Dec. 12, 2022 (GLOBE NEWSWIRE) — GPO Plus, Inc. (OTCQB: GPOX), a brand creation and distribution company focused on independent and regional retailers with an ever growing product catalog, that uses the power of Group Purchasing to save businesses money, announced they entered into an exclusive Trademark License Agreement with Yuengling’s Ice Cream for the creation of a full suite of Yuengling’s branded Ice Cream Flavored CBD and Cannabinoid products. Yuengling’s Ice Cream, founded...

Accomplished scientist with a diverse range of skills from general wet lab technique to company-wide operations management OCALA, Fla., Dec. 12, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today announced the promotion of Christopher McAleer, Ph.D., from Deputy Scientific Officer to Scientific Officer. “It is a great pleasure to work with such an accomplished scientist as Dr. McAleer. Chris is just as comfortable in the laboratory as he is dealing with Company operational management. Chris will make an excellent Scientific Officer,” said David Strayer, MD, AIM’s Chief...